NF-κB-activating complex engaged in response to EGFR oncogene inhibition drives tumor cell survival and residual disease in lung cancer.
Cell Reports
Blakely, Collin M CM; Pazarentzos, Evangelos E; Olivas, Victor V; Asthana, Saurabh S; Yan, Jenny Jiacheng JJ; Tan, Irena I; Hrustanovic, Gorjan G; Chan, Elton E; Lin, Luping L; Neel, Dana S DS; Newton, William W; Bobb, Kathryn L KL; Fouts, Timothy R TR; Meshulam, Jeffrey J; Gubens, Matthew A MA; Jablons, David M DM; Johnson, Jeffrey R JR; Bandyopadhyay, Sourav S; Krogan, Nevan J NJ; Bivona, Trever G TG